Use Salix Pharmaceuticals Ltd. management performance together with your assets to enhance returns of your portfolios as well as to check it against diversification policy that fits your risk preferences.
Salix Management Effectiveness
The company has return on total asset (ROA) of 8.12 % which means that it generated profit of $8.12 on every $1 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 21.98 % meaning that it created $21.98 on every dollar invested by stockholders.
Salix Profit Margins
The company has Profit Margin (PM) of 16.03 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 28.72 % which suggests for every dolor of sales it generated a net operating income of 0.29.
Salix Pharmaceuticals Ltd. is rated below average in number of employees category among related companies. The total workforce of Drugs - Generic industry is at this time estimated at about 27,890. Salix claims roughly 490 in number of employees contributing just under 2% to equities under Drugs - Generic industry.
CEO and President Director and Member of Pricing Committee
Ms. Carolyn J. Logan is President, Chief Executive Officer, Director of Salix Pharmaceuticals, Ltd., since July 2002. She previously served as Senior Vice President, Sales and Marketing from June 2000 to July 2002. ...
Mr. Thomas W. D'Alonzo is Independent Chairman of the Board of Salix Pharmaceuticals, Ltd. He has served as a member of Board of Directors since May 2000 and was the Chairman of the Board since June 2010. ...
Salix employes about 490 people. The company is managed by 13 executives with total tenure of roughly 46 years, averanging almost 3.0 years of service per executive having 37.0 employee per reported executive.
Return on Salix Manpower
Revenue Per Employee
1.2 M
Revenue Per Executive
46.6 M
Net Income Per Employee
198.1 K
Net Income Per Executive
7.5 M
Working Capital Per Employee
727.4 K
Working Capital Per Executive
27.4 M
Salix Earnings Per Share
According to company disclosure Salix Pharmaceuticals Ltd. has Earnings Per Share of 1.54 times. This is 45.28% higher than that of Healthcare sector, and 68.12% lower than that of Drugs - Generic industry, The Earnings Per Share for all stocks is 4.05% lower than the firm.
Earnings per Share is one of the most important measures of current share price of a firm, and is used by investors to determine company overall profitability especially when it is compared to EPS of similar companies.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
